Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,449.00
-30.30 (-2.05%)
Jan 7, 2026, 12:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 247.19 billion as of January 6, 2026. Its market cap has decreased by -2.38% in one year.
Market Cap
247.19B
Enterprise Value
236.08B
Revenue
26.00B
Ranking
n/a
PE Ratio
46.14
Stock Price
1,449.00
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 247.19B, an increase of 262.55%. That is a compound annual growth rate of 13.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 247.19B | -0.22% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 909.29B |
| Aurobindo Pharma | 705.91B |
| Fortis Healthcare | 690.60B |